Close

Biospecifics Technologies (BSTC) Announces Publication of Data for Uterine Fibroid Treatment with CCH

May 31, 2016 7:42 AM EDT Send to a Friend
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login